Insider Selling: Phreesia (NYSE:PHR) Insider Sells 6,038 Shares of Stock

Phreesia, Inc. (NYSE:PHR) insider David Linetsky sold 6,038 shares of the business’s stock in a transaction on Friday, January 16th. The stock was sold at an average price of $16.36, for a total value of $98,781.68. Following the sale, the insider owned 223,942 shares in the company, valued at $3,663,691.12. This represents a 2.63% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

David Linetsky also recently made the following trade(s):

• On Thursday, January 15th, David Linetsky sold 1,743 shares of Phreesia stock. The shares were sold at an average price of $16.38, for a total value of $28,550.34.
• On Thursday, January 8th, David Linetsky sold 6,106 shares of Phreesia stock. The shares were sold at an average price of $17.01, for a total value of $103,863.06.
• On Wednesday, December 17th, David Linetsky sold 94 shares of Phreesia stock. The stock was sold at an average price of $16.49, for a total value of $1,550.06.

Phreesia Trading Down 3.8%

NYSE PHR traded down $0.63 during trading hours on Tuesday, reaching $15.76. The company’s stock had a trading volume of 888,246 shares, compared to its average volume of 1,011,187. The firm has a fifty day simple moving average of $18.24 and a 200-day simple moving average of $23.18. The stock has a market cap of $950.23 million, a P/E ratio of -157.59 and a beta of 0.61. Phreesia, Inc. has a 52 week low of $15.41 and a 52 week high of $32.76. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44.

Phreesia (NYSE:PHR) last posted its earnings results on Monday, December 8th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.11. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The firm had revenue of $120.33 million for the quarter, compared to analyst estimates of $119.98 million. During the same period in the previous year, the firm posted ($0.25) EPS. The company’s revenue for the quarter was up 12.7% compared to the same quarter last year. Equities analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Phreesia

Several hedge funds and other institutional investors have recently bought and sold shares of PHR. Federated Hermes Inc. acquired a new position in shares of Phreesia during the third quarter valued at about $32,000. Asset Management One Co. Ltd. bought a new stake in Phreesia in the 3rd quarter valued at about $45,000. State of Alaska Department of Revenue acquired a new position in Phreesia during the 3rd quarter worth approximately $83,000. Farther Finance Advisors LLC raised its stake in Phreesia by 9,375.0% during the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after buying an additional 3,000 shares during the period. Finally, Anchor Investment Management LLC bought a new position in Phreesia in the third quarter worth approximately $118,000. 92.10% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Truist Financial set a $24.00 price objective on Phreesia in a research note on Thursday, January 8th. Robert W. Baird reduced their price objective on shares of Phreesia from $31.00 to $25.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 10th. Citigroup decreased their price objective on shares of Phreesia from $29.00 to $25.00 and set a “buy” rating for the company in a research report on Friday, January 9th. Barclays dropped their target price on shares of Phreesia from $26.00 to $24.00 and set an “overweight” rating on the stock in a report on Tuesday, December 16th. Finally, Mizuho decreased their price target on Phreesia from $36.00 to $28.00 and set an “outperform” rating for the company in a report on Wednesday, December 10th. Seventeen equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $30.06.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.